AzTrials
AzTrials

Death AnxietyExpressive ArtNCT07462936

Effect of Expressive Arts Therapy on Death Anxiety in Intensive Care Unit Nurses

A study testing Expressive Arts Therapy in people with Death Anxiety and Occupational Stress, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aimed to evaluate the effect of expressive arts therapy on death anxiety among intensive care unit nurses. A total of 66 nurses were randomly assigned to either an intervention group or a control group. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Expressive Arts Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2024to 13 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Registered nurses working in intensive care units At least 1 year of experience in an intensive care setting Having previously encountered patient death in clinical practice Willingness to participate in the study
  • Providing written informed Exclusion Criteria:
  • Currently receiving psychological or psychiatric treatment for severe mental health problems Participation in similar psychological or psychosocial intervention programs during the study period

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Samsun Training and Research Hospital

    Atakent, Samsun, 55200

Other trials in Turkey (Türkiye)

About this study

This randomized controlled trial aimed to evaluate the effect of expressive arts therapy on death anxiety among intensive care unit nurses. A total of 66 nurses were randomly assigned to either an intervention group or a control group. The intervention group participated in a structured expressive arts therapy programme consisting of weekly sessions for six weeks, while the control group received no intervention during the study period. Death anxiety levels were assessed using the Death Anxiety Scale before and after the intervention. The study aimed to determine whether expressive arts therapy is effective in reducing death anxiety and improving psychological well-being among intensive care unit nurses.

Read the detailed description

This randomized controlled study aimed to evaluate the effectiveness of a structured expressive arts therapy program in reducing death anxiety among intensive care unit nurses. Participants were randomly assigned to either an expressive arts therapy intervention group or a control group. The intervention consisted of six weekly sessions incorporating creative techniques such as drawing, clay work, and collage to facilitate emotional expression and reflection on experiences related to death and patient care. Death anxiety levels were assessed at baseline and immediately after the intervention using the Death Anxiety Scale. The study aimed to determine whether expressive arts therapy could reduce death anxiety and improve psychological well-being among intensive care nurses exposed to frequent patient mortality.

Being tested
Expressive Arts Therapy
Keywords
Expressive Arts Therapy, Death Anxiety, Intensive Care Unit Nurses, ICU Nurses, Randomized Controlled Trial, Psychological Intervention, Mental Health, Occupational Stress
Medical subject headings
Necrophobia, Occupational Stress, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Expressive Arts TherapyBehavioural

    Expressive arts therapy was delivered as a structured group intervention consisting of six weekly sessions including drawing, clay work, and collage.

Study groups in NCT07462936
Study groupRoleWhat they receive
Expressive Arts Therapy GroupExperimentalThis group participated in a structured expressive arts therapy programme consisting of weekly sessions for six weeks. Each session included creative activities such as drawing, clay work, and collage to facilitate emotional expression and processing of death-related experiences.
Receives: Behavioral: Expressive Arts Therapy
Control GroupNo interventionNo Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Death Anxiety Scale Total Score

    Death anxiety was assessed using the Death Anxiety Scale (DAS; Sarıkaya \& Baloğlu, 2016), a validated self-report instrument consisting of 20 items rated on a 5-point Likert scale (1-5).

    Total scores range from 20 to 100, with higher scores indicating greater levels of death anxiety.

    Measured: Baseline and Week 6 (post-intervention)

Secondary outcomes (2)
  1. Change in "Uncertainty About Death" Subscale Score

    The Uncertainty About Death subscale of the Death Anxiety Scale evaluates ambiguity and fear related to the unknown aspects of death.

    Subscale scores are derived from relevant items within the DAS, with higher scores indicating greater uncertainty and anxiety regarding death.

    Measured: Baseline and Week 6 (post-intervention)

  2. Change in "Thoughts About Death and Witnessing Death" Subscale Score

    This subscale measures cognitive and emotional responses related to thinking about death and exposure to dying individuals.

    Higher scores indicate more frequent and distressing death-related thoughts and experiences.

    Measured: Baseline and Week 6 (post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2026
  2. Study start1 Mar 2024
  3. Primary completion1 Jul 2024
  4. Study completion13 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study was conducted as a single-blind, parallel-group randomized controlled trial. Participants were randomly assigned in a 1:1 ratio to either the expressive arts therapy intervention group or the control group. The intervention group participated in a structured expressive arts therapy programme consisting of weekly sessions over six weeks, while the control group received no intervention during the study period. Outcome assessments were conducted at baseline and immediately after completion of the intervention. The outcome assessor was blinded to group allocation. The study aimed to compare the effectiveness of expressive arts therapy versus no intervention in reducing death anxiety among intensive care unit nurses.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07462936
Sponsor's protocol ID
OMU-BAP04-A-2024-5002-RCT
Other IDs
BAP04-A-2024-5002
Acronym
Expressive Art
Status last verified
Mar 2026
First submitted
28 Feb 2026
Last updated
30 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to ethical and confidentiality considerations. The dataset contains sensitive information collected from healthcare professionals, and sharing individual-level data was not included in the original informed consent or ethics approval. Only aggregated data are available within the published results.

Questions about this trial

What is this clinical trial studying?

A study testing Expressive Arts Therapy in people with Death Anxiety and Occupational Stress, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Death Anxiety Scale Total Score (time frame: Baseline and Week 6 (post-intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in